drugset / Trial / NCT03452397
Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the safety and effectiveness of OC-02 Nasal Spray as compared to placebo on signs and symptoms of dry eye disease.
Timeline
- Start
- 2018-02-27
- Primary completion
- 2018-04-27
- Completion
- 2018-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | simpinicline | Small molecule | 0.11 mg | Intranasal |
| Comparator | simpinicline | Small molecule | 0.55 mg | Intranasal |
| Comparator | simpinicline | Small molecule | 1.1 mg | Intranasal |